Population-based estimates of cancer survival (alongside incidence and mortality) provide valuable insights into the effectiveness of early-detection strategies and the quality of clinical care and management. Cancer survival is a key indicator of the effectiveness of cancer services and is a measure of prognosis that can reflect the prospects of clinical cure. SURVCAN and SURVMARK are international landmark projects in cancer survival, providing a comprehensive view of cancer survival in countries in transition and high-income countries, respectively. Together they will increase our understanding of the disparities in cancer survival and shed light on factors causing the observed variation.
DISCLAIMER
The Section of Cancer Surveillance (CSU) at IARC reserves the right to update or change the information contained on this website at any time, and is not responsible for information obtained via hyperlinks to external sites.
COPYRIGHT
IARC has proprietary rights to the material on this website. Publications/data made available by IARC/WHO enjoy copyright protection in accordance with the provisions of Protocol 2 of the Universal Copyright Convention. All rights are reserved. Materials (fact sheets, maps, estimates, or data) may be used ‘as is’ for research, educational, or other non-commercial purposes, but the corresponding reference must be cited in all instances. Requests for permission for any other use, including but not limited to use in conjunction with commercial purposes, should be addressed to publications@iarc.fr. Systematic retrieval of data to create or compile, directly or indirectly, a collection, database, or directory without explicit prior written permission from IARC is prohibited.
